60 Degrees Pharmaceuticals: Orca reports 5.6% stake
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
60 Degrees Pharmaceuticals, Inc. was the issuer in an ownership report by Orca Capital AG, which reported beneficial ownership of 222,934 shares of common stock, or 5.6% of the class. Orca's percentage calculation used 4,002,796 common shares and excluded 445,868 shares issuable upon exercise of warrants. The warrants are subject to a 4.99% blocker, which prevents exercise to the extent it would result in Orca beneficially owning more than 4.99% of the outstanding common stock.
Key Figures
Key Terms
beneficially owned regulatory
4.99% Blocker technical
sole dispositive power regulatory
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
AI-generated analysis. How Rhea-AI works. Not financial advice.